Please Wait
Applying Filters...
menu
    • menu
    ICE Pharma-PSE
    News
    New Zealand Pharmaceuticals Achieves Recertification for ISO 1400

    09 Dec 2025

    // PRESS RELEASE

    Bile Acids as Functional Excipients in Modern Drug Delivery

    25 Sep 2025

    // PRESS RELEASE

    Basaluzzo Site Renews GMP Certification from AIFA Until 2028

    19 Sep 2025

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    ICE S.p.A

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-supplier-spotlight/ice-pharma/corporate-video
    Menu

    ICE Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Bile acid

    02 1Cholic acid

    03 1Lithocholic acid

    04 1N-Acetyl-D-Mannosamine

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bile acid

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    41945-48-6
    Cholic Acid
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid...
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the treatment of liver diseases and gallstones. The company also develops bile acid derivatives used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma provides contract manufacturing for liquid and solid finished dosage forms for branded and generic products. Since October 2019, the company has been owned by Advent International, a global private equity investor. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    ICE S.p.A

    01

    Bile acid

    Italy
    BIO Partnering at JPM
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    Bile acid

    CAS Number : 41945-48-6

    End Use API : Cholic Acid

    About the Company : ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the trea...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cholic acid

    Intermediate Web Link

    Market Place

    6282-60-6
    Ursodeoxycholic Acid
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid...
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the treatment of liver diseases and gallstones. The company also develops bile acid derivatives used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma provides contract manufacturing for liquid and solid finished dosage forms for branded and generic products. Since October 2019, the company has been owned by Advent International, a global private equity investor. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    ICE S.p.A

    02

    Cholic acid

    Italy
    BIO Partnering at JPM
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    Cholic acid

    CAS Number : 6282-60-6

    End Use API : Ursodeoxycholic Acid

    About the Company : ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the trea...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Lithocholic acid

    Intermediate Web Link

    Market Place

    434-13-9
    Ursodeoxycholic Acid
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid...
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the treatment of liver diseases and gallstones. The company also develops bile acid derivatives used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma provides contract manufacturing for liquid and solid finished dosage forms for branded and generic products. Since October 2019, the company has been owned by Advent International, a global private equity investor. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    ICE S.p.A

    03

    Lithocholic acid

    Italy
    BIO Partnering at JPM
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    Lithocholic acid

    CAS Number : 434-13-9

    End Use API : Ursodeoxycholic Acid

    About the Company : ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the trea...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-Acetyl-D-Mannosamine

    Intermediate Web Link

    Market Place

    7772-94-3
    N-Acetyl-D-neuraminate
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid...
    ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the treatment of liver diseases and gallstones. The company also develops bile acid derivatives used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma provides contract manufacturing for liquid and solid finished dosage forms for branded and generic products. Since October 2019, the company has been owned by Advent International, a global private equity investor. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    ICE S.p.A

    04

    N-Acetyl-D-Mannosamine

    Italy
    BIO Partnering at JPM
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    N-Acetyl-D-Mannosamine

    CAS Number : 7772-94-3

    End Use API : N-Acetyl-D-neuraminate

    About the Company : ICE Pharma manufactures active pharmaceutical ingredients, with a core focus on Ursodeoxycholic Acid (UDCA) for the trea...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Ice Pharma and get a quotation

    Ice Pharma is a supplier offers 12 products (APIs, Excipients or Intermediates).

    Find a price of Ursodeoxycholic Acid bulk with DMF, CEP, JDMF offered by Ice Pharma

    Find a price of Chenodeoxycholic Acid bulk with DMF, CEP offered by Ice Pharma

    Find a price of Cholic Acid bulk with CEP, JDMF offered by Ice Pharma

    Find a price of Ursodeoxycholic Acid bulk with CEP offered by Ice Pharma

    Find a price of Cholic Acid bulk with CEP offered by Ice Pharma

    Find a price of Deoxycholic Acid bulk with CEP offered by Ice Pharma

    Find a price of Tauroursodeoxycholic Acid bulk with DMF offered by Ice Pharma

    Find a price of Dehydrocholic Acid bulk offered by Ice Pharma

    Find a price of Doxofylline bulk offered by Ice Pharma

    Find a price of Inosine Pranobex bulk offered by Ice Pharma

    Find a price of N-Acetyl-D-neuraminate bulk offered by Ice Pharma

    Find a price of Taurine bulk offered by Ice Pharma

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.